Cargando…

Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective

In recent years, the use of magnetic resonance imaging (MRI) for the diagnostic work-up of multiple sclerosis (MS) has evolved considerably. The 2017 McDonald criteria show high sensitivity and accuracy in predicting a second clinical attack in patients with a typical clinically isolated syndrome an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippi, Massimo, Preziosa, Paolo, Arnold, Douglas L., Barkhof, Frederik, Harrison, Daniel M., Maggi, Pietro, Mainero, Caterina, Montalban, Xavier, Sechi, Elia, Weinshenker, Brian G., Rocca, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971159/ https://www.ncbi.nlm.nih.gov/pubmed/36427168 http://dx.doi.org/10.1007/s00415-022-11488-y

Ejemplares similares

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis
por: Albergoni, Matteo, et al.
Publicado: (2022)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
por: Filippi, Massimo, et al.
Publicado: (2019)

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
por: Preziosa, Paolo, et al.
Publicado: (2022)

Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients
por: Santoro, Silvia, et al.
Publicado: (2022)

Mapping brain structure and function in professional fencers: A model to study training effects on central nervous system plasticity
por: Cordani, Claudio, et al.
Publicado: (2022)

Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020)

Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Neuroimaging features in inflammatory myelopathies: A review
por: Cacciaguerra, Laura, et al.
Publicado: (2022)

Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI
por: Zara, Pietro, et al.
Publicado: (2021)

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
por: Polman, Chris H, et al.
Publicado: (2011)

Editorial: “Inside-Out” vs “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
por: Luchicchi, Antonio, et al.
Publicado: (2021)

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES
por: Filippi, M., et al.
Publicado: (2016)

Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study
por: Kiljan, Svenja, et al.
Publicado: (2020)

Cognition in multiple sclerosis: State of the field and priorities for the future
por: Sumowski, James F., et al.
Publicado: (2018)

The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis
por: Rocca, Maria A., et al.
Publicado: (2017)

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective
por: Rocca, Maria A., et al.
Publicado: (2022)

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
por: Orrico, Mario, et al.
Publicado: (2021)

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis
por: Wottschel, Viktor, et al.
Publicado: (2019)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

Differential diagnosis of suspected multiple sclerosis: a consensus approach
por: Miller, DH, et al.
Publicado: (2008)

An Interpretable Machine Learning Model to Predict Cortical Atrophy in Multiple Sclerosis
por: Conti, Allegra, et al.
Publicado: (2023)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
por: Cohen, Jeffrey A, et al.
Publicado: (2016)

COVID-19 in teriflunomide-treated patients with multiple sclerosis
por: Maghzi, Amir Hadi, et al.
Publicado: (2020)

Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Imaging outcome measures for progressive multiple sclerosis trials
por: Moccia, Marcello, et al.
Publicado: (2017)

The Heart–Brain Interplay in Multiple Sclerosis from Pathophysiology to Clinical Practice: A Narrative Review
por: Zavarella, Matteo, et al.
Publicado: (2023)

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
por: Granziera, Cristina, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination
por: Bagella, Caterina Francesca, et al.
Publicado: (2021)

Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis
por: Platten, Michael, et al.
Publicado: (2022)

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
por: Elliott, Colm, et al.
Publicado: (2018)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration
por: Kearney, H, et al.
Publicado: (2014)

Reproductive history and progressive multiple sclerosis risk in women
por: Zeydan, Burcu, et al.
Publicado: (2020)

Ocrelizumab: a new milestone in multiple sclerosis therapy
por: Mulero, Patricia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6dq8uogl3snpvu5eqc0a5u3den